CORDIS
EU research results

CORDIS

English EN

The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance

Project information

Grant agreement ID: 860303

Status

Ongoing project

  • Start date

    1 October 2019

  • End date

    30 September 2023

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 2 672 561,88

  • EU contribution

    € 2 672 561,88

Coordinated by:

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

Project description

English EN

Profiling the messengers that cancer cells use to spread more than their word

In recent years, extracellular vesicles (EVs) have risen from relative obscurity to stardom. They are secreted by all cells and are now recognised as the carriers of biologically active molecules that travel to local or distant targets to mediate cell-cell communication. Cancer progression and metastasis is linked to EVs as these cells use EVs to export regulatory molecules like oncoproteins and oncopeptides. Further, EVs are found in bodily fluids, supporting their potential as blood-based or urine-based biomarkers as well as targets for cancer therapies. proEVLifeCycle is creating a dynamic team of researchers to enhance understanding of the lifecycle of EVs involved in prostate cancer to improve diagnosis and treatment of the most common cancer in men.

Coordinator

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Address

Dr Molewaterplein 40
3015 Gd Rotterdam

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 265 619,88

Participants (9)

CARDIFF UNIVERSITY

United Kingdom

EU Contribution

€ 303 172,56

TURUN YLIOPISTO

Finland

EU Contribution

€ 280 805,76

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

Austria

EU Contribution

€ 264 207,24

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS

Spain

EU Contribution

€ 250 904,88

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 274 802,04

FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III

Spain

EU Contribution

€ 250 904,88

GenomeScan B.V.

Netherlands

EU Contribution

€ 265 619,88

ANAXOMICS BIOTECH, S.L.

Spain

EU Contribution

€ 250 904,88

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

Netherlands

EU Contribution

€ 265 619,88

Project information

Grant agreement ID: 860303

Status

Ongoing project

  • Start date

    1 October 2019

  • End date

    30 September 2023

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 2 672 561,88

  • EU contribution

    € 2 672 561,88

Coordinated by:

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands